Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  alectinib
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
Status: Not yet active
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: BO29554, NCI-2017-01360, 2017-000076-28, NCT03178552
Alectinib and Bevacizumab in Treating Patients with ALK-positive Stage IIIB-IV Non-small Cell Lung Cancer
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-055, NCI-2015-01704, NCT02521051
Alectinib in Treating Patients with RET-Rearranged Stage IIIB-IV Non-small Cell Lung Cancer or RET-Mutated Stage IV Thyroid Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 17-080, NCI-2017-01201, NCT03131206
Start Over